在新诊断的多发性骨髓瘤中,单独或双重自主干细胞移植
Nora Grieb1,2, Alexander Oeser1, Maximilian Ferle1,2,3
1Innovation Center Computer Assisted Surgery (ICCAS), University of Leipzig, Leipzig, Germany.
Bone marrow transplantation
|December 5, 2024
概括
自主干细胞移植 (ASCT) 改善了多发性骨髓瘤的生存率. 双重ASCT的好处是选择的患者没有达到完全的反应,但仔细的选择至关重要,以避免更差的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞移植 干细胞移植
背景情况:
- 自主干细胞移植 (ASCT) 是新诊断的多发性骨髓瘤的关键治疗方法.
- 随着诱导和巩固策略的不断发展,需要对ASCT进行精细的患者选择.
研究的目的:
- 评估多发性骨髓瘤中单独与并联ASCT的不断变化的使用和结果.
- 为了确定患者子组,最受益于协同ASCT.
主要方法:
- 在1998年至2021年间,德国血造干细胞移植和细胞治疗 (DRST) 登记处的12763名患者的分析.
- 基于患者的特征和对治疗的反应,单个ASCT和双重ASCT之间的结果比较.
主要成果:
- 接受ASCT的人的中位数年龄增加,随着时间的推移,协同使用ASCT的比例下降.
- 整体存活率和无事件存活率在各年龄组显著改善,特别是在老年患者中.
- 双重ASCT在初始ASCT后未达到完全响应 (CR) 的患者中显示出益处,但与ISS III患者,功能障碍患者和获得CR的患者的较差结果有关.
结论:
- ASCT仍然是一个重要的抗髓瘤疗法.
- 仔细选择患者进行协同ASCT至关重要,避免在ISS III患者,功能障碍患者,老年患者或在初始ASCT后获得CR的患者中使用.
相关概念视频
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


